vs

Side-by-side financial comparison of Surgery Partners, Inc. (SGRY) and Tyler Technologies (TYL). Click either name above to swap in a different company.

Surgery Partners, Inc. is the larger business by last-quarter revenue ($885.0M vs $613.5M, roughly 1.4× Tyler Technologies). Tyler Technologies runs the higher net margin — 13.2% vs -1.7%, a 14.9% gap on every dollar of revenue. On growth, Tyler Technologies posted the faster year-over-year revenue change (8.6% vs 2.4%). Surgery Partners, Inc. produced more free cash flow last quarter ($90.6M vs $2.0M). Over the past eight quarters, Surgery Partners, Inc.'s revenue compounded faster (11.1% CAGR vs 6.5%).

United Surgical Partners International, Inc. (USPI) is an American ambulatory care company based in Dallas, Texas. It was founded by Don Steen in 1998.

Tyler Technologies, Inc. is an American technology company based in Plano, Texas, that provides proprietary software to the U.S. public sector. Tyler Technologies has offices in 17 states and one in Toronto, Ontario, Canada.

SGRY vs TYL — Head-to-Head

Bigger by revenue
SGRY
SGRY
1.4× larger
SGRY
$885.0M
$613.5M
TYL
Growing faster (revenue YoY)
TYL
TYL
+6.2% gap
TYL
8.6%
2.4%
SGRY
Higher net margin
TYL
TYL
14.9% more per $
TYL
13.2%
-1.7%
SGRY
More free cash flow
SGRY
SGRY
$88.6M more FCF
SGRY
$90.6M
$2.0M
TYL
Faster 2-yr revenue CAGR
SGRY
SGRY
Annualised
SGRY
11.1%
6.5%
TYL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
SGRY
SGRY
TYL
TYL
Revenue
$885.0M
$613.5M
Net Profit
$-15.0M
$81.2M
Gross Margin
48.3%
Operating Margin
12.5%
16.3%
Net Margin
-1.7%
13.2%
Revenue YoY
2.4%
8.6%
Net Profit YoY
86.2%
EPS (diluted)
$-0.11
$1.88

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SGRY
SGRY
TYL
TYL
Q1 26
$613.5M
Q4 25
$885.0M
$575.2M
Q3 25
$821.5M
$595.9M
Q2 25
$826.2M
$596.1M
Q1 25
$776.0M
$565.2M
Q4 24
$864.4M
$541.1M
Q3 24
$770.4M
$543.3M
Q2 24
$762.1M
$541.0M
Net Profit
SGRY
SGRY
TYL
TYL
Q1 26
$81.2M
Q4 25
$-15.0M
$65.5M
Q3 25
$-22.7M
$84.4M
Q2 25
$-2.5M
$84.6M
Q1 25
$-37.7M
$81.1M
Q4 24
$-108.5M
$65.2M
Q3 24
$-31.7M
$75.9M
Q2 24
$-15.5M
$67.7M
Gross Margin
SGRY
SGRY
TYL
TYL
Q1 26
48.3%
Q4 25
45.5%
Q3 25
47.2%
Q2 25
45.8%
Q1 25
47.3%
Q4 24
43.8%
Q3 24
43.7%
Q2 24
44.0%
Operating Margin
SGRY
SGRY
TYL
TYL
Q1 26
16.3%
Q4 25
12.5%
13.0%
Q3 25
12.9%
16.4%
Q2 25
13.5%
16.0%
Q1 25
8.0%
15.8%
Q4 24
14.7%
13.2%
Q3 24
7.9%
15.2%
Q2 24
11.1%
14.4%
Net Margin
SGRY
SGRY
TYL
TYL
Q1 26
13.2%
Q4 25
-1.7%
11.4%
Q3 25
-2.8%
14.2%
Q2 25
-0.3%
14.2%
Q1 25
-4.9%
14.3%
Q4 24
-12.6%
12.1%
Q3 24
-4.1%
14.0%
Q2 24
-2.0%
12.5%
EPS (diluted)
SGRY
SGRY
TYL
TYL
Q1 26
$1.88
Q4 25
$-0.11
$1.50
Q3 25
$-0.18
$1.93
Q2 25
$-0.02
$1.93
Q1 25
$-0.30
$1.84
Q4 24
$-0.86
$1.48
Q3 24
$-0.25
$1.74
Q2 24
$-0.12
$1.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SGRY
SGRY
TYL
TYL
Cash + ST InvestmentsLiquidity on hand
$239.9M
$346.4M
Total DebtLower is stronger
$3.6B
Stockholders' EquityBook value
$1.7B
$3.6B
Total Assets
$8.1B
$4.8B
Debt / EquityLower = less leverage
2.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SGRY
SGRY
TYL
TYL
Q1 26
$346.4M
Q4 25
$239.9M
$1.1B
Q3 25
$203.4M
$950.8M
Q2 25
$250.1M
$892.3M
Q1 25
$229.3M
$807.4M
Q4 24
$269.5M
$768.0M
Q3 24
$221.8M
$544.3M
Q2 24
$213.5M
$258.0M
Total Debt
SGRY
SGRY
TYL
TYL
Q1 26
Q4 25
$3.6B
$599.7M
Q3 25
$3.5B
$599.2M
Q2 25
$3.5B
$598.8M
Q1 25
$3.4B
$598.4M
Q4 24
$3.3B
$597.9M
Q3 24
$3.1B
$597.5M
Q2 24
$3.0B
$597.1M
Stockholders' Equity
SGRY
SGRY
TYL
TYL
Q1 26
$3.6B
Q4 25
$1.7B
$3.7B
Q3 25
$1.7B
$3.6B
Q2 25
$1.7B
$3.6B
Q1 25
$1.7B
$3.5B
Q4 24
$1.8B
$3.4B
Q3 24
$1.9B
$3.3B
Q2 24
$2.0B
$3.1B
Total Assets
SGRY
SGRY
TYL
TYL
Q1 26
$4.8B
Q4 25
$8.1B
$5.6B
Q3 25
$7.9B
$5.5B
Q2 25
$8.0B
$5.4B
Q1 25
$7.9B
$5.2B
Q4 24
$7.9B
$5.2B
Q3 24
$7.5B
$5.0B
Q2 24
$7.5B
$4.8B
Debt / Equity
SGRY
SGRY
TYL
TYL
Q1 26
Q4 25
2.10×
0.16×
Q3 25
2.00×
0.17×
Q2 25
1.98×
0.16×
Q1 25
1.98×
0.17×
Q4 24
1.83×
0.18×
Q3 24
1.63×
0.18×
Q2 24
1.56×
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SGRY
SGRY
TYL
TYL
Operating Cash FlowLast quarter
$103.4M
$107.3M
Free Cash FlowOCF − Capex
$90.6M
$2.0M
FCF MarginFCF / Revenue
10.2%
0.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
1.32×
TTM Free Cash FlowTrailing 4 quarters
$195.6M
$585.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SGRY
SGRY
TYL
TYL
Q1 26
$107.3M
Q4 25
$103.4M
$243.9M
Q3 25
$83.6M
$255.2M
Q2 25
$81.3M
$98.3M
Q1 25
$6.0M
$56.2M
Q4 24
$111.4M
$224.8M
Q3 24
$65.2M
$263.7M
Q2 24
$82.8M
$64.3M
Free Cash Flow
SGRY
SGRY
TYL
TYL
Q1 26
$2.0M
Q4 25
$90.6M
$239.6M
Q3 25
$63.8M
$251.3M
Q2 25
$57.9M
$92.8M
Q1 25
$-16.7M
$53.8M
Q4 24
$89.1M
$221.0M
Q3 24
$45.0M
$260.8M
Q2 24
$55.9M
$57.7M
FCF Margin
SGRY
SGRY
TYL
TYL
Q1 26
0.3%
Q4 25
10.2%
41.7%
Q3 25
7.8%
42.2%
Q2 25
7.0%
15.6%
Q1 25
-2.2%
9.5%
Q4 24
10.3%
40.8%
Q3 24
5.8%
48.0%
Q2 24
7.3%
10.7%
Capex Intensity
SGRY
SGRY
TYL
TYL
Q1 26
Q4 25
1.4%
0.8%
Q3 25
2.4%
0.7%
Q2 25
2.8%
0.9%
Q1 25
2.9%
0.4%
Q4 24
2.6%
0.7%
Q3 24
2.6%
0.5%
Q2 24
3.5%
1.2%
Cash Conversion
SGRY
SGRY
TYL
TYL
Q1 26
1.32×
Q4 25
3.72×
Q3 25
3.02×
Q2 25
1.16×
Q1 25
0.69×
Q4 24
3.45×
Q3 24
3.47×
Q2 24
0.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SGRY
SGRY

Private Insurance$460.5M52%
Government Revenue$368.6M42%
Other$19.8M2%
Self Pay Revenue$19.6M2%
Other Patient Service Revenue Sources$16.5M2%

TYL
TYL

Subscriptions$429.7M70%
Maintenance$108.9M18%
Other$74.9M12%

Related Comparisons